AMPHETAMINE SULFATE

N/A

Manufactured by Azurity Pharmaceuticals, Inc.

3,842 FDA adverse event reports analyzed

Last updated: 2026-04-15

About AMPHETAMINE SULFATE

AMPHETAMINE SULFATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Azurity Pharmaceuticals, Inc.. The most commonly reported adverse reactions for AMPHETAMINE SULFATE include TOXICITY TO VARIOUS AGENTS, DRUG ABUSE, COMPLETED SUICIDE, CARDIAC ARREST, DRUG INEFFECTIVE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AMPHETAMINE SULFATE.

Top Adverse Reactions

TOXICITY TO VARIOUS AGENTS601 reports
DRUG ABUSE456 reports
COMPLETED SUICIDE171 reports
CARDIAC ARREST112 reports
DRUG INEFFECTIVE100 reports
CARDIO RESPIRATORY ARREST93 reports
RESPIRATORY ARREST84 reports
HEADACHE70 reports
DRUG INTERACTION64 reports
OVERDOSE58 reports
FATIGUE57 reports
NAUSEA55 reports
ANXIETY51 reports
DIZZINESS51 reports
SUBSTANCE ABUSE50 reports
SOMNOLENCE49 reports
DEPRESSION45 reports
AGGRESSION44 reports
DEATH41 reports
FEELING ABNORMAL38 reports
RHABDOMYOLYSIS37 reports
FALL36 reports
INSOMNIA34 reports
AGITATION31 reports
ABNORMAL BEHAVIOUR29 reports
ASTHENIA29 reports
HYPERTENSION29 reports
IRRITABILITY29 reports
DIARRHOEA28 reports
PAIN28 reports
VOMITING28 reports
INTENTIONAL PRODUCT MISUSE27 reports
SEIZURE27 reports
DRUG TOXICITY26 reports
OFF LABEL USE26 reports
PULMONARY OEDEMA26 reports
TACHYCARDIA26 reports
LOSS OF CONSCIOUSNESS25 reports
SUICIDAL IDEATION25 reports
HYPOTENSION24 reports
CARDIOGENIC SHOCK23 reports
DYSPNOEA23 reports
DRUG DEPENDENCE22 reports
HYPERHIDROSIS22 reports
TREMOR22 reports
WEIGHT INCREASED22 reports
ACUTE KIDNEY INJURY21 reports
CONDITION AGGRAVATED21 reports
WEIGHT DECREASED21 reports
ACCIDENTAL OVERDOSE20 reports
BACK PAIN20 reports
DISTURBANCE IN ATTENTION20 reports
PRODUCT DOSE OMISSION ISSUE20 reports
COMA19 reports
PRURITUS19 reports
SUICIDE ATTEMPT19 reports
UNEVALUABLE EVENT19 reports
BLOOD PRESSURE INCREASED18 reports
EXPOSURE DURING PREGNANCY18 reports
PAIN IN EXTREMITY18 reports
INTENTIONAL OVERDOSE17 reports
MEMORY IMPAIRMENT17 reports
MIGRAINE17 reports
MYELOPATHY17 reports
PALPITATIONS17 reports
ANGER16 reports
CORONARY ARTERY DISSECTION16 reports
HEART RATE INCREASED16 reports
HYPOAESTHESIA16 reports
MALAISE16 reports
METABOLIC ACIDOSIS16 reports
STRESS CARDIOMYOPATHY16 reports
DECREASED APPETITE15 reports
DEPRESSED LEVEL OF CONSCIOUSNESS15 reports
ENCEPHALOPATHY15 reports
PNEUMONIA15 reports
PYREXIA15 reports
RASH15 reports
ROAD TRAFFIC ACCIDENT15 reports
ARTHRALGIA14 reports
CONFUSIONAL STATE14 reports
SUSPECTED SUICIDE14 reports
UNRESPONSIVE TO STIMULI14 reports
VISION BLURRED14 reports
CHEST PAIN13 reports
COVID 1913 reports
INJURY13 reports
MEDICATION ERROR13 reports
POISONING13 reports
PRODUCT QUALITY ISSUE13 reports
PRODUCT SUBSTITUTION ISSUE13 reports
PRODUCT USE IN UNAPPROVED INDICATION13 reports
PRODUCT USE ISSUE13 reports
PULMONARY CONGESTION13 reports
RESPIRATORY DEPRESSION13 reports
ABDOMINAL DISCOMFORT12 reports
BRAIN OEDEMA12 reports
COUGH12 reports
DISSEMINATED INTRAVASCULAR COAGULATION12 reports
INTENTIONAL DRUG MISUSE12 reports

Report Outcomes

Out of 2,128 classified reports for AMPHETAMINE SULFATE:

Serious 77.3%Non-Serious 22.7%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male1,045 (55.5%)
Female829 (44.0%)
Unknown8 (0.4%)

Reports by Age

Age 3052 reports
Age 3552 reports
Age 3648 reports
Age 2445 reports
Age 3744 reports
Age 3243 reports
Age 3443 reports
Age 3142 reports
Age 3342 reports
Age 2641 reports
Age 2841 reports
Age 5038 reports
Age 2136 reports
Age 2233 reports
Age 4032 reports
Age 4532 reports
Age 4831 reports
Age 2730 reports
Age 4730 reports
Age 2929 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with AMPHETAMINE SULFATE?

This profile reflects 3,842 FDA FAERS reports that mention AMPHETAMINE SULFATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for AMPHETAMINE SULFATE?

Frequently reported terms in FAERS include TOXICITY TO VARIOUS AGENTS, DRUG ABUSE, COMPLETED SUICIDE, CARDIAC ARREST, DRUG INEFFECTIVE, CARDIO-RESPIRATORY ARREST. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures AMPHETAMINE SULFATE?

Labeling and FAERS entries often list Azurity Pharmaceuticals, Inc. in connection with AMPHETAMINE SULFATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.